Marek Rosiak

415 total citations
33 papers, 328 citations indexed

About

Marek Rosiak is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pharmacology. According to data from OpenAlex, Marek Rosiak has authored 33 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 9 papers in Pharmacology. Recurrent topics in Marek Rosiak's work include Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Lipoproteins and Cardiovascular Health (7 papers) and Diabetes Treatment and Management (7 papers). Marek Rosiak is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Lipoproteins and Cardiovascular Health (7 papers) and Diabetes Treatment and Management (7 papers). Marek Rosiak collaborates with scholars based in Poland and United States. Marek Rosiak's co-authors include Marek Postuła, Grzegorz Opolski, Krzysztof J. Filipiak‬, Agnieszka Kapłon‐Cieślicka, Agnieszka Kondracka, Andrzej Członkowski, Piotr K. Janicki, Dariusz A. Kosior, Dagmara Mirowska-Guzeł and Michał Peller and has published in prestigious journals such as Journal of Thrombosis and Haemostasis, Diabetes/Metabolism Research and Reviews and Cardiovascular Diabetology.

In The Last Decade

Marek Rosiak

31 papers receiving 324 citations

Peers

Marek Rosiak
Mobin Dib Germany
Claudia E. Ramirez United States
Darren R. Davis Australia
Jijin Lin China
Sheldon Y. Freeberg United States
Marek Rosiak
Citations per year, relative to Marek Rosiak Marek Rosiak (= 1×) peers Hong-Dong Zhao

Countries citing papers authored by Marek Rosiak

Since Specialization
Citations

This map shows the geographic impact of Marek Rosiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Rosiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Rosiak more than expected).

Fields of papers citing papers by Marek Rosiak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Rosiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Rosiak. The network helps show where Marek Rosiak may publish in the future.

Co-authorship network of co-authors of Marek Rosiak

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Rosiak. A scholar is included among the top collaborators of Marek Rosiak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Rosiak. Marek Rosiak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peller, Michał, Ceren Eyileten, Marek Rosiak, et al.. (2021). Resistin is Associated with Inflammation and Renal Function, but not with Insulin Resistance in Type 2 Diabetes. Hormone and Metabolic Research. 53(7). 478–484. 4 indexed citations
2.
Peller, Michał, Agnieszka Kapłon‐Cieślicka, Marek Rosiak, et al.. (2020). Are adipokines associated with atrial fibrillation in type 2 diabetes?. Endokrynologia Polska. 71(1). 34–41. 8 indexed citations
3.
Kapłon‐Cieślicka, Agnieszka, Agata Tymińska, Marek Rosiak, et al.. (2018). Resistin is a prognostic factor for death in type 2 diabetes. Diabetes/Metabolism Research and Reviews. 35(2). e3098–e3098. 19 indexed citations
4.
Eyileten, Ceren, Dagmara Mirowska-Guzeł, M Zaremba, et al.. (2018). Serum Brain-Derived Neurotrophic Factor is Related to Platelet Reactivity and Metformin Treatment in Adult Patients With Type 2 Diabetes Mellitus. Canadian Journal of Diabetes. 43(1). 19–26. 21 indexed citations
5.
Janicki, Piotr K., Agnieszka Kapłon‐Cieślicka, Marek Rosiak, et al.. (2016). New single-nucleotide polymorphisms associated with differences in platelet reactivity and their influence on survival in patients with type 2 diabetes treated with acetylsalicylic acid: an observational study. Acta Diabetologica. 54(4). 343–351. 9 indexed citations
6.
7.
Postuła, Marek, Piotr K. Janicki, Marek Rosiak, et al.. (2016). Targeted deep resequencing of ALOX5 and ALOX5AP in patients with diabetes and association of rare variants with leukotriene pathways. Experimental and Therapeutic Medicine. 12(1). 415–421. 2 indexed citations
8.
Kapłon‐Cieślicka, Agnieszka, Marek Postuła, Marek Rosiak, et al.. (2015). Association of adipokines and inflammatory markers with lipid control in type 2 diabetes. Polskie Archiwum Medycyny Wewnętrznej. 125(6). 414–423. 19 indexed citations
9.
Szymańska, Urszula, et al.. (2015). Large thrombus entrapped in a patent foramen ovale complicated by stroke and pulmonary embolism. Polskie Archiwum Medycyny Wewnętrznej. 125(9). 690–691. 1 indexed citations
10.
Postuła, Marek, et al.. (2014). Emerging treatments in type 2 diabetes: focus on canagliflozin. Therapeutics and Clinical Risk Management. 10. 683–683. 16 indexed citations
11.
Postuła, Marek, Piotr K. Janicki, Marek Rosiak, et al.. (2013). Association of plasma concentrations of salicylic acid and high on ASA platelet reactivity in type 2 diabetes patients. Cardiology Journal. 20(2). 170–7. 8 indexed citations
14.
Rosiak, Marek, Marek Postuła, Agnieszka Kapłon‐Cieślicka, et al.. (2013). Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: The AVOCADO study. Cardiology Journal. 20(5). 545–551. 17 indexed citations
15.
Postuła, Marek, Piotr K. Janicki, Marek Rosiak, et al.. (2013). Effect of common single nucleotide polymorphisms in COX-1 gene on related metabolic activity in diabetic patients treated with acetylsalicylic acid. Archives of Medical Science. 6(6). 1198–1205. 2 indexed citations
16.
Rosiak, Marek, Marek Postuła, Agnieszka Kapłon‐Cieślicka, et al.. (2013). Lack of effect of common single nucleotide polymorphisms in leukotriene pathway genes on platelet reactivity in patients with diabetes. Molecular Medicine Reports. 8(3). 853–860. 5 indexed citations
17.
Kapłon‐Cieślicka, Agnieszka, Marek Rosiak, Marek Postuła, et al.. (2013). Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. Kardiologia Polska. 71(9). 893–902. 18 indexed citations
18.
Postuła, Marek, Piotr K. Janicki, Marek Rosiak, et al.. (2012). New single nucleotide polymorphisms associated with differences in platelets reactivity in patients with type 2 diabetes treated with acetylsalicylic acid: genome-wide association approach and pooled DNA strategy. Journal of Thrombosis and Thrombolysis. 36(1). 65–73. 18 indexed citations
19.
Postuła, Marek, Agnieszka Kapłon‐Cieślicka, Marek Rosiak, et al.. (2011). Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes. Journal of Thrombosis and Haemostasis. 9(11). 2291–2301. 47 indexed citations
20.
Rosiak, Marek. (2009). INVESTIGATING THE (NON)EXISTENCE OF THE PURELY INTENTIONAL OBJECT (W sprawie (nie)istnienia przedmiotu czysto intencjonalnego). 17. 13–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026